Critical appraisal of extended-release hydrocodone for chronic pain: patient considerations
Harry J Gould III,1,3–7 Dennis Paul1–8 1Department of Neurology, 2Department of Pharmacology and Experimental Therapeutics, 3Department of Internal Medicine, Section of Physical Medicine and Rehabilitation, 4Department of Anesthesiology, 5Neuroscience Center of Excellence, 6Cente...
Saved in:
Main Authors: | Gould HJ III (Author), Paul D (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of food and alcohol on the pharmacokinetics of an oral, extended-release formulation of hydrocodone in healthy volunteers
by: Farr SJ, et al.
Published: (2015) -
Preclinical and Clinical Pharmacology of Hydrocodone for Chronic Pain: A Mini Review
by: Luigi Cardia, et al.
Published: (2018) -
Critical appraisal of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia
by: Ayman A Hussein, et al.
Published: (2010) -
Dynamic Changes in the Distribution of Hydrocodone and Oxycodone in Florida from 2006 to 2021
by: Elena Lynn Stains, et al.
Published: (2024) -
Development of a New Type of Prolonged Release Hydrocodone Formulation Based on Egalet® ADPREM Technology Using In Vivo-In Vitro Correlation
by: Jean-Michel Cardot, et al.
Published: (2011)